VF
MNPR icon

Virtu Financial’s Monopar Therapeutics MNPR Stock Holding History

Virtu Financial’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,009
Closed -$654K – 2039
2025
Q4 		$654K Buy
+10,009
New +$818K 0.03% 495
2024
Q3 		– Sell
-3,768
Closed -$14K – 1684
2024
Q2 		$14K Sell
3,768
-997
-21% -$3.51K ﹤0.01% 1082
2024
Q1 		$16K Sell
4,765
-669
-12% -$1.99K ﹤0.01% 1197
2023
Q4 		$9K Buy
+5,434
New +$11K ﹤0.01% 1419

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtu Financial's MNPR Position: Q1 2026 in Review

Virtu Financial sold out of Monopar Therapeutics (MNPR) in Q1 2026, closing a stake of 10,009 shares — an estimated $654K sold.

Virtu Financial first reported a position in MNPR in Q4 2023 and held it in 4 quarters. The position peaked at $654K in Q4 2025. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • Virtu Financial reported no remaining Monopar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,009 Monopar Therapeutics shares in Q1 2026, an estimated $654K.
  • Virtu Financial first reported a position in Monopar Therapeutics in Q4 2023 and held it in 4 quarters.
  • Virtu Financial's Monopar Therapeutics position peaked at $654K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.